scholarly article | Q13442814 |
P50 | author | Christopher Moskaluk | Q57441216 |
P2093 | author name string | Yuki Yamaguchi | |
Hiroshi Handa | |||
Rong Li | |||
Sarah E Aiyar | |||
Amitava Mukherjee | |||
Da-ming Ren | |||
Qi-Nong Ye | |||
Jian-long Sun | |||
Ashley L Blair | |||
Yun-zhe Lu | |||
P2860 | cites work | BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations | Q24291985 |
ERAP140, a conserved tissue-specific nuclear receptor coactivator | Q24295032 | ||
Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex | Q24296462 | ||
Disassembly of transcriptional regulatory complexes by molecular chaperones | Q24300055 | ||
Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. | Q24537283 | ||
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor | Q24555775 | ||
Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II | Q24562164 | ||
JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction | Q24675100 | ||
Transcription elongation factors repress transcription initiation from cryptic sites. | Q27931897 | ||
Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae | Q27937704 | ||
The coregulator exchange in transcriptional functions of nuclear receptors | Q28131759 | ||
NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation | Q28141291 | ||
Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation | Q28141828 | ||
FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH | Q28141838 | ||
Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor | Q28142019 | ||
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity | Q28204456 | ||
Putting tumours in context | Q28207789 | ||
Combinatorial control of gene expression by nuclear receptors and coregulators | Q28209095 | ||
Structure-function analysis of the estrogen receptor alpha corepressor scaffold attachment factor-B1: identification of a potent transcriptional repression domain | Q28254928 | ||
Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta | Q28587815 | ||
CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators | Q28594257 | ||
An extensive network of coupling among gene expression machines | Q29547273 | ||
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures | Q29547700 | ||
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription | Q29547846 | ||
A unified theory of gene expression | Q29615022 | ||
Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter | Q29616537 | ||
SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. | Q30176471 | ||
Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain | Q30193837 | ||
Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain | Q30306336 | ||
Identification and characterization of estrogen receptor variants in prostate cancer cell lines | Q30306798 | ||
Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence | Q33837377 | ||
Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. | Q33890400 | ||
The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation | Q33911291 | ||
Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings | Q33932063 | ||
RNA polymerase II elongation through chromatin | Q34058567 | ||
Mechanisms of estrogen action | Q34093297 | ||
Estrogen receptor pathways to AP-1. | Q34132667 | ||
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms | Q34171522 | ||
Transcription elongation: the 'Foggy' is liftingellipsis. | Q34183941 | ||
Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo | Q34224771 | ||
Estrogens and cell-cycle regulation in breast cancer | Q34336956 | ||
The mRNA assembly line: transcription and processing machines in the same factory | Q34688409 | ||
Taking the study of cancer cell survival to a new dimension | Q35036517 | ||
Endocrine-responsive breast cancer and strategies for combating resistance | Q35084786 | ||
High-resolution localization of Drosophila Spt5 and Spt6 at heat shock genes in vivo: roles in promoter proximal pausing and transcription elongation | Q35205005 | ||
NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila | Q35965503 | ||
Spt5 and spt6 are associated with active transcription and have characteristics of general elongation factors in D. melanogaster | Q40445025 | ||
A slow RNA polymerase II affects alternative splicing in vivo | Q40627617 | ||
Elongation inhibition by DRB sensitivity-inducing factor is regulated by the A20 promoter via a novel negative element and NF-kappaB. | Q40633614 | ||
Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction | Q40964604 | ||
Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. | Q41035943 | ||
Enhancement of human estrogen receptor activity by SPT6: a potential coactivator | Q41393826 | ||
Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription | Q41684614 | ||
A regulator of transcriptional elongation controls vertebrate neuronal development | Q46382831 | ||
Ligand-independent activation of steroid hormone receptors | Q47862014 | ||
Characterization of the proximal estrogen-responsive element of human cathepsin D gene | Q48082268 | ||
Carcinogenesis: A superfamily of potentially oncogenic hormone receptors | Q59077092 | ||
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells | Q60568779 | ||
Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity | Q71877215 | ||
The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators | Q74265958 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | estrogen | Q277954 |
P304 | page(s) | 2134-2146 | |
P577 | publication date | 2004-09-01 | |
P1433 | published in | Genes & Development | Q1524533 |
P1476 | title | Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor | |
P478 | volume | 18 |
Q37244303 | A Role of CREB in BRCA1 Constitutive Promoter Activity and Aromatase Basal Expression |
Q37333813 | A conserved protein motif is required for full modulatory activity of negative elongation factor subunits NELF-A and NELF-B in modifying glucocorticoid receptor-regulated gene induction properties |
Q37095266 | A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis |
Q24536049 | A negative elongation factor for human RNA polymerase II inhibits the anti-arrest transcript-cleavage factor TFIIS. |
Q33944154 | A phosphotyrosine switch determines the antitumor activity of ERβ. |
Q42426276 | Architecture and RNA binding of the human negative elongation factor. |
Q33850983 | Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis. |
Q26853262 | BRCA1, a 'complex' protein involved in the maintenance of genomic stability |
Q36978246 | BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes |
Q36561822 | Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription |
Q39999414 | Cellular dynamics of the negative transcription elongation factor NELF. |
Q30439381 | Cofactor of BRCA1 modulates androgen-dependent transcription and alternative splicing |
Q30444129 | Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells |
Q39958759 | Cotranscriptional splicing potentiates the mRNA production from a subset of estradiol-stimulated genes. |
Q37075889 | Enforcing the pause: transcription factor Sp3 limits productive elongation by RNA polymerase II. |
Q89845940 | Estrogen receptor alpha (ERα)-mediated coregulator binding and gene expression discriminates the toxic ERα agonist diethylstilbestrol (DES) from the endogenous ERα agonist 17β-estradiol (E2) |
Q79756268 | Expression and distribution of trihydrophobin 1 in postnatal developing mouse testis |
Q37293773 | FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth |
Q49936294 | Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development. |
Q50101639 | Gene-specific mechanisms direct Glucocorticoid Receptor-driven repression of inflammatory response genes in macrophages |
Q35658278 | Gene-specific recruitment of positive and negative elongation factors during stimulated transcription of the MKP-1 gene in neuroendocrine cells. |
Q35378348 | Genetic and genomic analyses of RNA polymerase II-pausing factor in regulation of mammalian transcription and cell growth |
Q36670266 | Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development. |
Q33355172 | Genome-wide analysis of alternative promoters of human genes using a custom promoter tiling array |
Q40130067 | Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters |
Q37157412 | Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle |
Q33702169 | HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb |
Q34666783 | Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells |
Q37351081 | Hormone-regulated transcriptomes: lessons learned from estrogen signaling pathways in breast cancer cells |
Q37073709 | Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. |
Q33673701 | Human negative elongation factor activates transcription and regulates alternative transcription initiation |
Q37416607 | Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling. |
Q33953149 | Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complex |
Q36964490 | Kinetic competition between elongation rate and binding of NELF controls promoter-proximal pausing |
Q36419269 | Kinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction |
Q33737855 | Module Discovery by Exhaustive Search for Densely Connected, Co-Expressed Regions in Biomolecular Interaction Networks |
Q24798796 | Molecular characterization of Drosophila NELF |
Q28475186 | Mouse cofactor of BRCA1 (Cobra1) is required for early embryogenesis. |
Q90187891 | NELF Regulates a Promoter-Proximal Step Distinct from RNA Pol II Pause-Release |
Q36710845 | NELF and GAGA factor are linked to promoter-proximal pausing at many genes in Drosophila |
Q28474810 | NELF potentiates gene transcription in the Drosophila embryo |
Q36802956 | NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly |
Q37151045 | Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription |
Q45405018 | Negative elongation factor NELF represses human immunodeficiency virus transcription by pausing the RNA polymerase II complex |
Q38629873 | Negative elongation factor accelerates the rate at which heat shock genes are shut off by facilitating dissociation of heat shock factor |
Q39663904 | Negative role of trihydrophobin 1 in breast cancer growth and migration |
Q36974098 | Pausing for thought: disrupting the early transcription elongation checkpoint leads to developmental defects and tumourigenesis. |
Q34494012 | Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation. |
Q37099958 | Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes |
Q36237484 | Promoter proximal pausing and the control of gene expression |
Q37284766 | Promoter proximal pausing on genes in metazoans |
Q36505626 | RNA polymerase II pausing as a context-dependent reader of the genome |
Q29615047 | RNA polymerase is poised for activation across the genome |
Q24645367 | RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo |
Q38562823 | Ready, pause, go: regulation of RNA polymerase II pausing and release by cellular signaling pathways |
Q30441905 | Regulation of clustered gene expression by cofactor of BRCA1 (COBRA1) in breast cancer cells |
Q40362927 | Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells |
Q40273664 | The BRCA1 COOH-terminal region acts as an RNA polymerase II carboxyl-terminal domain kinase inhibitor that modulates p21WAF1/CIP1 expression |
Q36602565 | The role of BRCA1 in transcriptional regulation and cell cycle control |
Q36759836 | Transcription factor Sp3 represses expression of p21CIP¹ via inhibition of productive elongation by RNA polymerase II. |
Q35855656 | Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression |
Q38408801 | Transcriptional pausing caused by NELF plays a dual role in regulating immediate-early expression of the junB gene |
Q24307973 | Transcriptional regulation of BRCA1 expression by a metabolic switch |
Q35641521 | Translational Initiation at a Non-AUG Start Codon for Human and Mouse Negative Elongation Factor-B |
Q34125340 | Trihydrophobin 1 phosphorylation by c-Src regulates MAPK/ERK signaling and cell migration |
Q35812718 | Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. |
Q37520630 | Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancer |
Q34795516 | What goes on behind closed doors: physiological versus pharmacological steroid hormone actions |
Search more.